| 题名 | Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas:an open-label, multicentre,randomised, phase 3 non-inferiority trial |
| 链接 | http://www.ncbi.nlm.nih.gov/pubmed/23433739 |
| 欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |